Cipla Medpro to acquire 30 per cent stake in Brandmed
Cipla had announced a similar partnership in India with Wellthy Therapeutics to offer a clinically-validated digital disease…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin receives FDA approval for Fluoxetine Tablets USP
Lupin’s Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly’s Prozac Tablets, 10 mg and 20 mg
Lupin…
Hovione Technology announces acquisition of global rights to new pulmonary inhaler device – the…
Papillon DPI is a single-part, blister-based, reusable inhaler of extreme simplicity, suitable for both chronic and acute…
Cabinet approves MoU between India and Bolivia on cooperation for traditional systems of medicine…
The MoU will lead to promotion and propagation of traditional systems of medicine and homoeopathy, and will boost the importance…
China-based innovation, CDMOs and parallel approvals driving huge growth in manufacturing at CPhI…
Significant increase in exhibitors driven by bio growth at bioLIVE and separate nutraceuticals event, CPhI Annual Report,
Suven gets US court’s approval to buy assets of Rising Pharmaceuticals
The company has completed a 'stalking horse agreement' as mandated by a bankruptcy court to buy the assets of Rising…
Dr Reddy’s Laboratories announces acquisition of ANDA portfolio
The portfolio includes more than 30 generic injectable products and could be launched within the next one to two years
Johnson & Johnson works to accelerate patient access to bedaquiline
Through its Janssen Pharmaceutical Companies, Johnson & Johnson donated more than 10,000 courses of bedaquiline in 2016 as…
Sitaram Gupta from Lupin Foundation bags ‘India CSR Lifetime Achievement Award’
Gupta received the award for his extraordinary contribution towards social development
Lupin launches Testosterone Gel
Lupin’s Testosterone Gel, 1.62 per cent (20.25 mg/1.25 g pump actuation), is the generic equivalent of AbbVie Inc’s AndroGel, 1.62…
Cipla launches Niveoli – India’s first extra-fine ICS-LABA combination HFA inhaler
Niveoli is a proprietary Cipla inhaler that addresses an unmet need associated with obstructive airway diseases (OAD) such as…
Indian Pharma sector growth to moderate at 8-10% CAGR over FY’2018-21: ICRA
High base for domestic business impacted Q3FY2019 growth, and moderation in pricing pressure, new launches and currency…
Wockhardt receives US FDA approval for cancer drug
This is the third US FDA approval for an oncology product for Wockhardt during the past three months
US FDA approves ViiV Healthcare’s Dovato
Dovato strengthens ViiV Healthcare’s industry-leading portfolio of innovative treatment approaches for people living with HIV
Lupin launches Fluoxetine tabs
The drug is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa
Global eye care giant Alcon lists at Swiss Exchange
The listing is expected to be one of Europe’s largest in the coming year and will be split across SIX and the NYSE
Intas Pharma launches Trastuzumab biosimilar
Eleftha will bring down the treatment cost by 65 per cent
CCRH to organise international convention on World Homoeopathy Day
The convention will deliberate on linking education and clinical practice with research
IndiaRF invests $144 million in Panacea Biotec
Investment to be used for one-time settlement with existing lenders, working capital and growth requirements
Bayer Animal Health launches Seresto in India
Seresto is designed to deal with the vagaries of climate change and the resultant rise in temperatures across the globe that makes…